Free Trial
NASDAQ:CLBT

Cellebrite DI (CLBT) Stock Price, News & Analysis

Cellebrite DI logo
$19.12 +0.05 (+0.26%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$19.36 +0.24 (+1.28%)
As of 02/21/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Cellebrite DI Stock (NASDAQ:CLBT)

Key Stats

Today's Range
$18.93
$19.66
50-Day Range
$19.07
$26.00
52-Week Range
$10.24
$26.30
Volume
3.55 million shs
Average Volume
2.35 million shs
Market Capitalization
$3.94 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.43
Consensus Rating
Buy

Company Overview

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company was incorporated in 1999 and is headquartered in Petah Tikva, Israel.

Cellebrite DI Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
59th Percentile Overall Score

CLBT MarketRank™: 

Cellebrite DI scored higher than 59% of companies evaluated by MarketBeat, and ranked 152nd out of 322 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cellebrite DI has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Cellebrite DI has only been the subject of 3 research reports in the past 90 days.

  • Read more about Cellebrite DI's stock forecast and price target.
  • Earnings Growth

    Earnings for Cellebrite DI are expected to grow by 20.00% in the coming year, from $0.30 to $0.36 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cellebrite DI is -13.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cellebrite DI is -13.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Cellebrite DI has a PEG Ratio of 4.27. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Cellebrite DI has a P/B Ratio of 11.73. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.11% of the float of Cellebrite DI has been sold short.
  • Short Interest Ratio / Days to Cover

    Cellebrite DI has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cellebrite DI has recently decreased by 18.46%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Cellebrite DI does not currently pay a dividend.

  • Dividend Growth

    Cellebrite DI does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.11% of the float of Cellebrite DI has been sold short.
  • Short Interest Ratio / Days to Cover

    Cellebrite DI has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cellebrite DI has recently decreased by 18.46%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Cellebrite DI has a news sentiment score of 0.73. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Business Services companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Cellebrite DI this week, compared to 4 articles on an average week.
  • Search Interest

    Only 13 people have searched for CLBT on MarketBeat in the last 30 days. This is a decrease of -43% compared to the previous 30 days.
  • MarketBeat Follows

    9 people have added Cellebrite DI to their MarketBeat watchlist in the last 30 days. This is an increase of 13% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cellebrite DI insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 5.70% of the stock of Cellebrite DI is held by insiders.

  • Percentage Held by Institutions

    45.88% of the stock of Cellebrite DI is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Cellebrite DI's insider trading history.
Receive CLBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cellebrite DI and its competitors with MarketBeat's FREE daily newsletter.

CLBT Stock News Headlines

This simple indicator removes the “technical” out of technical trading
Experts are calling it the best buy/sell indicator of 2024… A finance whiz from northern Florida has coded an indicator that isolates the precise dates to buy in and out of the stock market. According to the creator, it allows him to ride all the market highs yet sidestep the lows. And for the first time ever, he’s sharing his indicator with the public. As you’ll see in today’s free trading session, you simply buy when the candles turn green and sell when they turn red.
Cellebrite price target raised to $30 from $25 at TD Cowen
Cellebrite price target raised to $27 from $24 at Deutsche Bank
See More Headlines

CLBT Stock Analysis - Frequently Asked Questions

Cellebrite DI's stock was trading at $22.03 on January 1st, 2025. Since then, CLBT stock has decreased by 13.2% and is now trading at $19.12.
View the best growth stocks for 2025 here
.

Cellebrite DI Ltd. (NASDAQ:CLBT) announced its quarterly earnings results on Thursday, February, 13th. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.10 by $0.03. Cellebrite DI had a positive trailing twelve-month return on equity of 58.70% and a negative net margin of 70.54%.

Cellebrite DI's top institutional shareholders include True Wind Capital Management L.P. (6.73%), FMR LLC (5.16%), Axon Enterprise Inc. (4.37%) and Nine Ten Capital Management LLC (1.75%).

Shares of CLBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cellebrite DI investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), TotalEnergies (TTE) and Southern First Bancshares (SFST).

Company Calendar

Last Earnings
2/13/2025
Today
2/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
Computer Software
Current Symbol
NASDAQ:CLBT
Employees
1,008
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$23.43
High Stock Price Target
$28.00
Low Stock Price Target
$17.00
Potential Upside/Downside
+22.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
8 Analysts

Profitability

Net Income
$-283,010,000.00
Pretax Margin
-68.79%

Debt

Sales & Book Value

Annual Sales
$401.20 million
Cash Flow
$0.37 per share
Book Value
$1.63 per share

Miscellaneous

Free Float
194,194,000
Market Cap
$3.94 billion
Optionable
Optionable
Beta
1.47

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:CLBT) was last updated on 2/23/2025 by MarketBeat.com Staff
From Our Partners